Add BrightSurf on Google Email

Low cholesterol cues cataract development

Cataract formation is linked to cholesterol biosynthesis defects. Epithelial cells in the lens mature abnormally, leading to opacity. The study identifies a connection between cholesterol synthesis and cataract development.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 26, 2006

Arterial leg disease may be more common in blacks

A recent study found that African-Americans are more likely to develop arterial leg disease, a condition that can lead to amputation if left untreated. Cigarette smoking is the single most important risk factor for the disease, which is also associated with hypertension, diabetes, and high cholesterol levels.

SourceCenter for Advancing Health·JournalAmerican Journal of Preventive Medicine·DateDec 20, 2005

No reason to fear very low LDL

Researchers analyzed data from a large trial and found no safety concerns for patients with very low LDL levels. The study suggests that intensive statin therapy may be beneficial even when LDL levels drop below targeted levels.

SourceAmerican College of Cardiology·JournalJournal of the American College of Cardiology·DateOct 11, 2005

JCI table of contents October 3, 2005

A new study published in The Journal of Clinical Investigation found that decreased function of the CREB gene transcription factor is involved in anxiety and excessive alcohol drinking behavior. Decreased CREB function was shown to be important for maintaining high anxiety and excessive alcohol drinking. This genetic determinant create...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 3, 2005

Hopkins experts highlight strategies to raise levels of so-called good HDL cholesterol

Researchers highlight the importance of raising HDL cholesterol levels, citing a link between higher levels and lower risk of fatal heart attacks. They recommend lifestyle modifications such as regular exercise, weight control, and dietary changes to boost HDL levels, and discuss the benefits and potential risks of drug therapy.

SourceJohns Hopkins Medicine·JournalNew England Journal of Medicine·DateSep 21, 2005

JCI table of contents September 1, 2005

Researchers have identified the Dido gene as a potential tumor suppressor in myelodysplastic/myeloproliferative diseases. Additionally, SOCS-7 has been found to regulate insulin signaling and enhance insulin action. Furthermore, aldose reductase expression has been linked to accelerated diabetic atherosclerosis in transgenic mice.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 25, 2005

JCI table of contents September 1, 2005

Researchers have solved a 72-year-old mystery surrounding cholesterol production, revealing that Insig proteins play a crucial role in regulating this process. The study found that mice lacking these proteins accumulate excessive cholesterol and fat in the liver, highlighting the importance of Insig in maintaining normal lipid metabolism.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 11, 2005

Aspirin treatment failure warning

Research reveals that aspirin resistance is a significant concern for certain patient groups, particularly those with coronary heart disease or high cholesterol levels. An alternative treatment option, Clopidogrel, has shown promise in reducing blood clotting and inflammation in these patients.

JCI table of contents August 1, 2005

Researchers discover hemoglobin's novel function as a nitrite reductase, generating nitric oxide to regulate vasodilation. Separate studies reveal that M cells are not necessary for oral tolerance induction, while bacterial infections can break B cell tolerance by activating self-reactive B cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 21, 2005

Poly/mono balance important to cholesterol-lowering diet

A new Penn State study found that a balanced diet with both polyunsaturated fatty acids (PUFAs) and monounsaturated fatty acids (MUFAs) is essential for lowering cholesterol levels. The study compared two heart-healthy oils, sunflower oil and olive oil, in a diet designed to reduce blood cholesterol.

SourcePenn State·JournalJournal of the American Dietetic Association·DateJul 1, 2005

Smoking and inflammation

A study on smokers and non-smokers found that it takes several years for changes in the blood to return to normal after smoking. After quitting, the inflammatory response had returned to normal by five years, highlighting the importance of quitting smoking. This finding emphasizes the health benefits of smoking cessation.

SourcePLOS·JournalPLOS Medicine·DateJun 27, 2005

Elevated CRP can foil diet's ability to lower cholesterol

A recent study published in the Journal of Nutrition found that individuals with elevated C-reactive protein (CRP) levels cannot lower their LDL-cholesterol numbers with a Step 1 diet, even when soy protein is added. The study suggests that habitual consumption of a Step 1 diet may be beneficial for those with low CRP levels but delete...

SourcePenn State·JournalJournal of Nutrition·DateJun 20, 2005

New benefits of soy revealed

Researchers found that soy-based meal replacements led to greater weight loss and improved cholesterol levels compared to milk-based alternatives. Additionally, soy intake was shown to reduce serum glucose values, suggesting a role in maintaining overall health and slowing diabetes development.

SourceUniversity of Kentucky·JournalJournal of the American College of Nutrition·DateJun 7, 2005

Metabolic syndrome prevalent in heart attack patients

A study examined the prevalence of metabolic syndrome in heart attack patients and found that 46% met the criteria. Patients with metabolic syndrome were older, more likely to be women, and had worse in-hospital outcomes, including increased risk of heart failure.

SourceJAMA Network·JournalArchives of Internal Medicine·DateMay 23, 2005

Fat's fate depends on its source

A new study published in Cell Metabolism found that normal metabolism requires so-called "new" fat to maintain glucose, lipid, and cholesterol homeostasis. The researchers discovered that old fat stores alone failed to set critical metabolic pathways in motion, leading to a marked decline in gene activity.

SourceCell Press·JournalCell Metabolism·DateMay 10, 2005

Excess liver gene protects against high-fat diet

A new study reveals that mice with an excess of liver X receptor (LXRa) are protected from high-fat diet-induced cholesterol and blood vessel plaques. The findings suggest that natural variation in LXRa levels can influence susceptibility to heart disease, depending on diet.

SourceCell Press·JournalCell Metabolism·DateMay 10, 2005

Atorvastatin shows promise in small trial for the treatment of mild to moderate Alzheimer's disease

A small-scale trial of atorvastatin calcium found significant reductions in circulating cholesterol levels and potential benefits on cognitive function and behavior in patients with mild to moderate Alzheimer's disease. The results hold promise for the treatment of AD, but further multicenter trials are needed to confirm these findings.

SourceJAMA Network·JournalArchives of Neurology·DateMay 9, 2005

Liver may be source of 'good' cholesterol

Researchers at Wake Forest University School of Medicine have found that the liver is the main source of high-density lipoprotein (HDL), or 'good' cholesterol. This discovery could lead to new treatments for raising HDL levels, particularly in individuals with less severe cholesterol disorders.

SourceAtrium Health Wake Forest Baptist·JournalJournal of Clinical Investigation·DateApr 8, 2005

How HDL keeps the heart healthy

A study published in the Journal of Clinical Investigation reveals that HDL (high-density lipoprotein) activates an enzyme called eNOS, leading to a cellular signal that depends on cholesterol efflux. The activation of eNOS is mediated by two intact domains of SR-BI, which act as 'cholesterol sensors' triggering cellular events.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 24, 2005

JCI table of contents April 1, 2005

Researchers developed a new mouse model that mimics the effects of low-dose aspirin therapy, exploring its impact on blood clotting and reproductive functions. The study suggests that low-dose aspirin treatment may prevent preeclampsia without compromising reproductive function.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 17, 2005